Abstract
Generating live attenuated vaccines through repeated passages in cells and animals has been standard procedure for more than a century. A more targeted approach may lie on the horizon (pages 154–161).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
